Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
- Author(s): Bacchetti, Peter
- Braithwaite, Dejana
- Waubant, Emmanuelle
- Castillo-Trivino, T
- et al.
Published Web Locationhttp://europepmc.org/articles/PMC3699597?pdf=render
Background: Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. Objectives: To evaluate the efficacy and safety of rituximab for MS treatment. Data collec